IP Library Patent Application 15462498
Patent Application
App. No. 15/462,498

USE OF FUSION PROTEINS TO IMPROVE THE AVAILABILITY OF ANTIGENIC PEPTIDE EPITOPES IN IMMUNOASSAYS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/462,498
Abstract

Methods, techniques, systems and compositions to reduce or prevent the aggregation and/or epitope masking of control/calibration peptides. The methods described herein may be particularly helpful for calibration and quantifying target proteins from immunoassays such as solid-phase enzyme immunoassays (EIAs).

Claims (20)

1 . A method of quantifying a target protein from a patient sample using a synthetic calibration protein having increased solubility, the method comprising:

performing an immunoassay on the patient sample using an antibody to the target protein;

generating a plurality of calibration solutions comprising different concentrations of a fusion protein of a synthetic target protein and Glutathione S-transferase (GST) in a detergent solution; and

using the plurality of calibration solutions to calibrate the immunoassay and provide a concentration of the target protein, wherein the different concentrations of the calibration solutions correspond to molar concentrations of the fusion protein without value-assigning the concentrations to determine the concentration of the target protein.

2 . The method of claim 1 , further comprising using the plurality of calibration solutions to make a calibration curve.

3 . The method of claim 1 , wherein the immunoassay is a solid-phase enzyme immunoassay (EIA).

4 . The method of claim 1 , wherein the patient sample is a blood sample.

5 . The method of claim 1 , wherein the target protein is NT-proBNP.

6 . The method of claim 1 , wherein the target protein is β Amyloid peptide (AB42).

7 . The method of claim 1 , wherein the target protein is MR-proANP.

8 . The method of claim 1 , wherein the fusion protein comprises a His6 Tag (SEQ ID NO: 3).

9 . The method of claim 1 , wherein the fusion protein comprises a TEV cleavage site between the target protein and the GST.

10 . The method of claim 1 , wherein the fusion protein comprises the GST fused to the C-terminus of the target protein.

11 . The method of claim 1 , wherein the fusion protein comprises the GST fused to the N-terminus of the target protein.

12 . The method of claim 1 , wherein the detergent solution comprises one or more of: an anionic surfactant, a nonionic surfactant, a zwitterionic detergent, and a chaotropic agent.

13 . The method of claim 1 , wherein the detergent solution comprises one or more of: Sodium dodecyl sulfate (SDS), Triton X-100, Tergitol-type NP-40 (NP-40), octylphenoxypolyethoxyethanol (IGEPAL CA-630), 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS), and Guanidine Hydrochloride.

14 . A method of quantifying a target protein from a patient sample using a synthetic calibration NT-proBNP having increased solubility, the method comprising:

performing an immunoassay on the patient sample using an antibody to NT-proBNP;

generating a plurality of calibration solutions comprising different concentrations of a fusion protein of a synthetic NT-proBNP and Glutathione S-transferase (GST) in a detergent solution; and

using the plurality of calibration solutions to calibrate the immunoassay and provide a concentration of the NT-proBNP from the immunoassay, wherein the different concentrations of the calibration solutions correspond to molar concentrations of the fusion protein without value-assigning the concentrations to determine the concentration of the target protein.